As we are seeing an upturn in the requirement for excellent Quality staff, we thought it’d be interesting to collate the course that can lead to the QP or “Qualifed Person” status in Ireland.

Trinity College, Dublin (TCD) – MSc / Postgrad Diploma in Pharmaceutical Manufacturing Technology

Royal College of Surgeons in Ireland (RCSI) – MSc in Industrial Pharmaceutical Technology

IT Sligo – MSc in Industrial Pharmaceutical Technology

Edit – there’s University College, Cork (UCC) also – Masters in Pharmaceutical Technology and Quality Systems

To our knowledge these are the 4 currently on offer. Most are run on a 2 year part-time basis, where attendance is required a number of times per semester. They are semi-distance learning, so to speak. The requirements for these courses are generally just a scientific degree plus 2+ years of Quality experience in a regulated industry. They are a great way to kick-start your career if the support network within your current employer exists.

For relevant quality opportunities, check out our QualityAssurance.ie site.

Comments or questions? – Brian (brian.c at lifescience.ie)

We’ve all been writing web-content in our sleep, with the result that there are many new sites live and would really appreciate you taking the time to look through and them and mot importantly…LET US KNOW YOUR THOUGHTS.

Connected Health.ie: the first recruitment site in Ireland focussed towards this growing area of the economy. A recent conference highlighted this, at which Eamonn and Brian were proud sponsors and advertisers. Brian’s LinkedIn group is almost at 50 members, please do join up if you’re active in this area.

Pharmaceutical.ie – has just been relaunched, we think its a lot more relevant and useful, with career profiles and industry advice in different sub-areas of the Pharmaceutical industry.

Biotechnology.ie – were quite proud of picking up this domain name when we did! The site is colourful, functional and will constantly evoloving according to Client and Candidate demands as things progress, like all of our sites. FYI Mr Conor Lenihan, evolution DOES exist!!!

MedicalDevice.ie – James is delighted to launch this, he also created a LinkedIn group to support it. The site is getting a lot of traffic as it’s one area of the economy as whole which seems to be gathering some momentum.

Eamonn was featured in the Sunday Business Post this week – the link is here. Apologies for the SBP site link, it’s not great, is it?!

We’ll be launching and re-launching some more sites in the next 2 weeks, announcements will be made here and on Twitter / Facebook as we go along. Outside of these announcements we’ve all had a great Summers, even though we’re not really looking forward to finishing work when it’s dark in the evenings!

As always we’re delighted to hear your feedback on the sites, particularly the new ones above.

-Brian (bhc at lifescience dot ie)

All Life Science jobseekers should check out this video: HERE.

It’s 4 Irish industry leaders: Owen Treacy (GM, Novo Nordisk Ireland), David Lloyd (Dean of Research, TCD), Joe Keenan (Director Sales & Marketing, Argutus Medical) and Michael Gillen (Bioindustry Ireland). There are various tips contained within about how to distinguish yourself from your peers, how to sell yourself to people like them in industry, and how to get that first step on the ladder.

We get a lot of call from graduates and people with <1 years experience who are seeking to advance in industry. Although there aren’t as many opportunities as 2 years ago, following the advice provided here will set you well on your way. The concept of working for free is mentioned. Although I would agree with Doug Richard that working for free is not a great idea (it can create the wrong dynamic), certainly being flexible in your approach is the way to go to get that first notch on your CV.

I’d love to hear any thoughts you have on the above.

-Brian (bhc at lifescience dot ie)

I feel the same goes for start-up company names. I would love to know how much time people spend thinking them up. They have to be short, zingy and most important of all: PSEUDO-SCIENTIFIC!!!

Some common terms:

-cel (diagnostics / life science companies)

-bio (for life science / biotech)

-pharma

-med (for medical device companies)

If you can squeeze two into your company name your chances of success are immediately doubled.

Mix these pre/suffixes with terms like vista- (Life) vas- (the cardiac system), tek-, tech- (it’s cutting edge!) or similar. If you want to absolutely guarantee success, follow the rules above and it will result in stock market floatation and a huge pay-off for founding company directors within 5 years*

Disclaimer: we are aware of the irony of our own company name!

*not a guarantee

-Brian (bhc at lifescience.ie)

Brian Christensen from Life Science Recruitment examines how the recent economic difficulties have affected the Life Sciences industry in Ireland.

The Life Science industry in Ireland has weathered the economic storm relatively unscathed. A sweeping statement perhaps? But one we believe to be true. There are a number of points to be noted when assessing the current situation.

The Brain Drain

With 1,000 PhD’s scheduled to graduate this year, are there job for these candidates? Currently, it seems, the answer is no. Reliable PhD employers like Wyeth/Pfizer have frozen recruitment due to the current merger. Recruitment has also slowed down in relation to PhD recruitment with Abbott. The overwhelming result is that more PhDs are staying in academia, and are not contributing ideas to industry. Many are seeking work in more buoyant markets and also outside mainstream science – in areas such as sales and marketing and business consultancy. However, on the commercialization of research, there seems to be light at the end of the tunnel.

A 7.5% increase in capital committed to start ups in 2008 was noted, which was also 26% up on 2006. Many of these start-ups are based around special incubation centres on university campuses like the Nova Centre in UCD and the Ignite Centre in Galway. The take-home message seems to be there are still attractive and viable options out there for ambitious researchers who have pioneering technology to bring to market. Recent success stories include Cappella Medical Devices in Galway and Merrion Pharma in Dublin.

Governmental Plans

For those that suggest preparation is key, our governmental organisations would tend to agree, certainly judging by recent actions. The IDA and Enterprise Ireland (EI) in recent times have sourced planning application approvals for 2 “plug and play” Biopharma campuses, one based in Galway and the other in Dundalk. This makes it easier for these bodies to attract potential Clients, although the argument could be made for the apparent lack of potential new blockbuster drugs in the current global pipeline which would warrant such sites. However, having these options ready to go means we are gearing up for the market to shift in the right direction, and positioning correctly for when new investments need to be made. Another issue on the horizon is how long can we keep hold of our magical 12.5% corporate tax rate? Obama has made it clear that it is something he is not happy about, and the EU has sent signals to similar effect. This could have a hugely detrimental effect on all sectors of our economy were it to ultimately materialise.

Recent Industry Movements

There have been a number of new investments in the country this year, including the further development of the Athlone Medical Device hub, encompassing companies like Teleflex, Utah Medical, Abiomed, KCI Medical, Georgia Tech, as well as the clinical research organisation PPD. Other investments and expansions include worldwide manufacturers like Millipore in Cork and Merck-Sharpe & Dohme in Carlow. This is encouraging when considering Ireland within the scheme of global markets; we are still an attractive place to invest. However, a number of questions still linger. The most pertinent of these would seem to be the fallout from Pfizer’s purchase of Wyeth. As Wyeth has a number of high profile plants here in Ireland, it will be interesting how Pfizer judges them in the global context of their operations. The Grange Castle site would seem to be in good hands due to its modernity, but the Newbridge site is 38 years old, so may not have a future quite so bright.

Job Areas to Focus On

On a more micro level, we have noticed a number of areas where job shortages seem to be present, at least from our viewpoint. As there has been a historical lack of biotech in this country, experience up- and downstream process engineers, as well as micro professionals with biotech experience, are strongly in demand. Regulatory affairs have been tightened up in recent times, resulting in a constant need to regulatory professionals in various areas. We are also noticed a lot of outsourcing in this area. There has been a lot of expansion in the Clinical Affairs / Clinical Research area. Larger companies like ICON and Quintiles are going strong, with numerous smaller companies making market gains with pioneering new technologies like electronic data capture (EDC). As EDC is something relatively new to the CRO marketplace, companies are still coming to terms with the regulatory adjustments necessary to accommodate it, resulting in a number of positions here. In Clinical Affairs, niche specialist roles like medical advisory and medical science liaison roles seems to be in constant demand.

Job Seeking

We have also examined how the web-savvy jobseeker who is on the lookout has adapted to these difficulties and market needs. According to our research, almost 70% of people have started to use multiple resourcing techniques, such as direct searches on search engines as opposed to just job boards. There is also a trend toward a more niche targeted jobseeker, with many opting for niche industry job sites and industry specialist portals, such as lifescience.ie. People are using social networks to connect and talk, which inevitably results in people finding jobs here too. LinkedIn, Facebook and twitter (to a lesser extent) are being embraced by the informed jobseeker. Google searches are becoming more popular as internet penetration continues to rise. In a market as tough as this, it pays to have a number of people who are taking a keen interest in any potential opportunities available, which these sites do perfectly. We see this market as continuing to adapt as new and better technologies become available. We would describe the forecast for next year as being cautious but quietly optimistic, although it will very much be governed by decisions by the global players who have made the aforementioned market shifting moves.

Areas we’re particularly busy in currently:

Reg Affairs – we are working on some very interesting work in this area on the Medical Devices / Diagnostics side of things. Anyone with significant experience in this area – do get in touch! These skills are particularly in demand for companies launching new products or new start-up organisations developing / taking over new products. The trend towards more specific and niche products means more regulatory (and associated quality) filings, valuable skill sets to have for the future.

Biotech professionals – vacancies in various areas here, engineering / production / quality / micro etc. It’s a chicken and egg scenario, as biotech is not an area we as a country have explored greatly in the past, although this is changing somewhat. Overseas and other candidate are encouraged to contact us.

Sales and Marketing – - Medical Device Sales Specialist, Hospital Sales Reps and Business Managers are all high on the target list.

Outside Science: currently it’s music to lift us all out of the post-Marathon – cold, winter blues. This week I have attended Martin Hayes & Dennis Cahill (amazing!) and have plans for Muse and the Diversus Guitar Orchestra this weekend…

Following on from last month – Google Wave really underwhelmed didn’t it? Dublinbikes seem to be taking off though

-Brian (bhc at lifescience dot ie)